TruSight RNA Pan-Cancer Panel

TruSight RNA Pan-Cancer Panel

The TruSight RNA Pan-Cancer Panel enables comprehensive detection of gene fusions, variants and gene expression changes in cancer samples, providing researchers with a focused view of the functionally relevant changes occurring. The panel is compatible with FFPE tissue, accommodating as little as 10 ng of fresh-frozen total RNA input or 20ng of FFPE RNA input. The TruSight RNA Pan-Cancer Panel provides a sensitive, reproducible, and economical solution for studies of expression dynamics and functional mechanisms in cancer.

Starting material: 

The protocol is optimized for 10–100 ng of human total RNA.

  • Lower amounts might result in low yield and reduced sensitivity.
  • The protocol has been tested using 10 ng of high-quality universal human reference total RNA as input.
  • Use of RNA from other tissues or lower quality RNA might require further optimization to determine the input amount.
FFPE RNA Input Recommendations
Quality DV200 Input Requirements Per Reaction
High > 70% 20 ng
Medium 50–70% 20–50 ng
Low 30–50% 50–100 ng
Too Degraded < 30% Not recommended

Please rotate your device for details

Project Recommendations
Species Compatibility Human
Recommended Illumina Instrument* MiniSeq MiSeq
Recommended Samples per Run 2 to 3 8 8 (v3 chemistry)
Max Recommended Read Length 2×75 bp 2×75 bp 2×75 bp
Recommended Secondary Analysis RNA-seq (FASTQ) RNA-seq (FASTQ)
Recommended Down Stream Analysis BaseSpace RNA-Seq Alignment App BaseSpace RNA-Seq Alignment App

*Library prep is compatible with all Illumina instruments. Recommended instruments chosen based on typical output and analysis need for selected application.

† Based on 3M reads per sample.

Product and Ordering Information

  • TruSight RNA Pan-Cancer Panel Set A (48 samples): RS-303-1002
  • TruSight RNA Pan-Cancer Panel Set B (48 samples): RS-303-1003